ClinicalTrials.Veeva

Menu

Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Active, not recruiting

Conditions

Breast Carcinoma

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06584396
NCI-2023-05588 (Registry Identifier)
2023-0320

Details and patient eligibility

About

This study evaluates the skin and surrounding soft tissue that is removed during an implant reconstruction after a mastectomy.

Full description

PRIMARY OBJECTIVE:

I. Characterize the nanomechanical properties of the skin and adjacent soft tissue removed at the time of postmastectomy implant reconstruction.

OUTLINE: This is an observational study.

Patients undergo tissue collection during standard of care surgery, have their medical records reviewed, and complete questionnaires throughout the study.

Enrollment

140 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • * Age 18 and older

    • Female sex
    • Patient with history of mastectomy with tissue expander placement
    • Tissue expander in place at time of study enrollment
    • Patient plans to undergo surgery to exchange tissue expander for permanent breast implant within the next 3 months of signing the informed consent
    • Ability to understand and provide written informed consent in accordance with institutional policies

Trial design

140 participants in 1 patient group

Observational
Description:
Patients undergo tissue collection during standard of care surgery, have their medical records reviewed, and complete questionnaires throughout the study.
Treatment:
Other: Non-Interventional Study

Trial contacts and locations

1

Loading...

Central trial contact

Benjamin Smith, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems